Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.1.1 (
hexokinase
)
5,274
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Hexokinase (
ATP:D-hexose 6-phosphotransferase
,
EC 2.7.1.1
) has been synthesized in the rabbit reticulocyte lysate system directed by poly(A)+ mRNA isolated from rat brain. Identification of the in vitro synthesis product as
hexokinase
was based on its immunoprecipitation with anti-
hexokinase
serum as well as the generation of identical peptide maps after partial cleavage of the in vitro product and authentic
hexokinase
with Staphylococcus aureus
V8 proteinase
or chymotrypsin. The in vitro product and authentic
hexokinase
were indistinguishable in molecular weight (SDS-gel electrophoresis); thus, despite the fact that, in situ, much of the
hexokinase
in brain is found in association with mitochondria, it is not synthesized in the form of a higher molecular weight precursor as is characteristic of other mitochondrial proteins. This is in accord with the view that
hexokinase
is best considered as a classical 'soluble' enzyme which is capable of exhibiting reversible association with mitochondria. The in vitro product cochromatographs (during anion-exchange HPLC) with authentic
hexokinase
previously shown to have a blocked (presumably acetylated) N-terminus; this procedure is capable of resolving the N-terminally blocked form of the enzyme from a partially proteolyzed form having a free N-terminal amino group. Thus the in vitro product is apparently N-acetylated by an enzyme system previously shown to be present in reticulocyte lysates. A significant fraction of the in vitro synthesized
hexokinase
attained a conformation characteristic of the native enzyme as judged by the observations that it could be immunoprecipitated by monoclonal antibodies recognizing the native enzyme but not by antibodies recognizing denatured
hexokinase
, and limited tryptic cleavage of the in vitro product gave fragments identical to those seen with the native enzyme and thought to reflect the organization of structural domains in that enzyme. However, based on these same criteria, the majority of the
hexokinase
synthesized in vitro appears to exist in a folding state that is not identical to that of either the fully denatured or native enzyme.
...
PMID:In vitro synthesis of rat brain hexokinase. 286 81